Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder
Clinical trial NCT00108836 · COMPLETED
Trial details
- NCT number
- NCT00108836
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.